Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Nuclear Medicine/Radiopharmaceuticals Market to reach USD 8.76 billion by 2028.

Global Nuclear Medicine/Radiopharmaceuticals Market Size study, By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes), By Application (SPECT Applications, PET Applications, Therapeutic Applications), By Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures), and Regional Forecasts 2022-2028

Product Code: HLSDT-40268625
Publish Date: 20-04-2022
Page: 200

Global Nuclear Medicine/Radiopharmaceuticals Market is valued approximately USD 4.80 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2028.

Nuclear medicine is also known as radiopharmaceuticals or medicinal radio compounds, which is a set of pharmaceutical drugs that comprises radioactive isotopes. Nuclear medicine is a form of medical specialty that includes the application of radioactive substances in the diagnosis and treatment of target diseases. The growing incidence and prevalence of target conditions such as cancer, cardiovascular, and neurological disorders, rising awareness of radiopharmaceuticals, and rising development of the alpha-radioimmunotherapy-based targeted cancer treatments are the primary factors that are surging the market demand across the globe. According to the National Cancer Institute, in 2018, cancer was is one of the major reasons for the highest deaths accounting for 18.1 million new cases and 9.5 million cancer-related deaths globally. Also, it is expected that the amount will reach 29.5 million and the number of cancer-related deaths to 16.4 million by the end of 2040. Thereby, the rising prevalence of cancer is propelling demand for radiopharmaceuticals, thus, in turn, impelling the market growth. Moreover, the rising inclination towards the Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans and the increasing number of initiatives to meet the demand & supply gap of Mo-99 is further accelerating the market growth. However, the short half-life of radiopharmaceuticals and hospital budget cuts, and high equipment costs impede the growth of the market over the forecast period of 2022-2028. Also, the use of radiopharmaceuticals in neurological applications and growing investment in R&D activities are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Nuclear Medicine/Radiopharmaceuticals market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the development of novel technologies for radioisotope production, growing incidences of Alzheimer’s disease, Parkinson’s disease, and availability of government funding. Whereas, North America is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the increasing R&D expenditure, as well as the rising presence of the leading market players in the region, would create lucrative growth prospects for the Nuclear Medicine/Radiopharmaceuticals market across the North American region.

Major market players included in this report are:
Cardinal Health Inc.
GE Healthcare Company
Curium SAS
Lantheus Medical Imaging Inc.
Bayer AG
Bracco Imaging Inc.
Eczacýbaþý-Monrol Nuclear Products
Nordion Inc.
Advanced Accelerator Applications
NTP Radioisotopes SOC Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Brachytherapy Isotopes
By Application
SPECT Applications
PET Applications
Therapeutic Applications
By Procedural Volume Assessment
Diagnostic Procedures
Therapeutic Procedures
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Nuclear Medicine/Radiopharmaceuticals Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Nuclear Medicine/Radiopharmaceuticals Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Nuclear Medicine/Radiopharmaceuticals Market, by Type, 2020-2028 (USD Billion)
1.2.3. Global Nuclear Medicine/Radiopharmaceuticals Market, by Applications, 2020-2028 (USD Billion)
1.2.4. Global Nuclear Medicine/Radiopharmaceuticals Market, by Procedural Volume Assessment, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nuclear Medicine/Radiopharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine/Radiopharmaceuticals Market Dynamics
3.1. Nuclear Medicine/Radiopharmaceuticals Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of target conditions
3.1.1.2. Development of alpha-radioimmunotherapy-based targeted cancer treatments
3.1.2. Market Challenges
3.1.2.1. Short half-life of radiopharmaceuticals
3.1.2.2. Hospital budget cuts and high equipment costs
3.1.3. Market Opportunities
3.1.3.1. Use of radiopharmaceuticals in neurological applications
3.1.3.2. Increasing investment in the R&D activities
Chapter 4. Global Nuclear Medicine/Radiopharmaceuticals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Nuclear Medicine/Radiopharmaceuticals Market, by Type
6.1. Market Snapshot
6.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Type, Performance – Potential Analysis
6.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
6.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Diagnostic Nuclear Medicine
6.4.2. Therapeutic Nuclear Medicine
6.4.3. Brachytherapy Isotopes
Chapter 7. Global Nuclear Medicine/Radiopharmaceuticals Market, by Applications
7.1. Market Snapshot
7.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Applications, Performance – Potential Analysis
7.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Applications 2018-2028 (USD Billion)
7.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
7.4.1. SPECT Applications
7.4.2. PET Applications
7.4.3. Therapeutic Applications
Chapter 8. Global Nuclear Medicine/Radiopharmaceuticals Market, by Procedural Volume Assessment
8.1. Market Snapshot
8.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment, Performance – Potential Analysis
8.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Procedural Volume Assessment 2018-2028 (USD Billion)
8.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
8.4.1. Diagnostic Procedures
8.4.2. Therapeutic Procedures
Chapter 9. Global Nuclear Medicine/Radiopharmaceuticals Market, Regional Analysis
9.1. Nuclear Medicine/Radiopharmaceuticals Market, Regional Market Snapshot
9.2. North America Nuclear Medicine/Radiopharmaceuticals Market
9.2.1. U.S. Nuclear Medicine/Radiopharmaceuticals Market
9.2.1.1. Type estimates & forecasts, 2018-2028
9.2.1.2. Applications estimates & forecasts, 2018-2028
9.2.1.3. Procedural Volume Assessment estimates & forecasts, 2018-2028
9.2.2. Canada Nuclear Medicine/Radiopharmaceuticals Market
9.3. Europe Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.3.1. U.K. Nuclear Medicine/Radiopharmaceuticals Market
9.3.2. Germany Nuclear Medicine/Radiopharmaceuticals Market
9.3.3. France Nuclear Medicine/Radiopharmaceuticals Market
9.3.4. Spain Nuclear Medicine/Radiopharmaceuticals Market
9.3.5. Italy Nuclear Medicine/Radiopharmaceuticals Market
9.3.6. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market
9.4. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.4.1. China Nuclear Medicine/Radiopharmaceuticals Market
9.4.2. India Nuclear Medicine/Radiopharmaceuticals Market
9.4.3. Japan Nuclear Medicine/Radiopharmaceuticals Market
9.4.4. Australia Nuclear Medicine/Radiopharmaceuticals Market
9.4.5. South Korea Nuclear Medicine/Radiopharmaceuticals Market
9.4.6. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market
9.5. Latin America Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.5.1. Brazil Nuclear Medicine/Radiopharmaceuticals Market
9.5.2. Mexico Nuclear Medicine/Radiopharmaceuticals Market
9.6. Rest of The World Nuclear Medicine/Radiopharmaceuticals Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Cardinal Health Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. GE Healthcare Company
10.2.3. Curium SAS
10.2.4. Lantheus Medical Imaging Inc.
10.2.5. Bayer AG
10.2.6. Bracco Imaging Inc.
10.2.7. Eczacýbaþý-Monrol Nuclear Products
10.2.8. Nordion Inc.
10.2.9. Advanced Accelerator Applications
10.2.10. NTP Radioisotopes SOC Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now